Pfizer
OpenCalais Metadata: Ticker
Pfizer - Δρ. Άλμπερτ Μπουρλά: Ο ιός είναι ο εχθρός - Γιατί είναι ασφαλές το εμβόλιό μας
Ο χρόνος είναι αντίπαλος, δηλώνει ο Έλληνας CEO της Pfizer
UK asks regulator to study AstraZeneca vaccine
The British government said on Nov. 27 it has asked its independent medicines regulator to assess AstraZeneca's coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.
- Read more about UK asks regulator to study AstraZeneca vaccine
- Log in to post comments
Turkey inks contract for 50 million doses of Chinese vaccine
Turkey has signed a contract to buy 50 million doses of the COVID-19 vaccine from China's Sinovac Biotech, Health Minister Fahrettin Koca has said.
Turkey has a deal for 50 million doses of China's Sinovac vaccine that will be delivered in December, January, and February, according to the minister.
Vučić announced: Meeting scheduled, main topic - urgent procurement of vaccines PHOTO
"Urgent procurement of vaccines is the only topic of today's meeting with representatives of the Institute of Virology, Vaccines and Serums 'Torlak', the Institute of Public Health of Serbia 'Dr Milan Jovanovic Batut', the Drug Agency and the RHIF," Vucic said, along with photos from the meeting on the official account of "Budunostsrbije" on Instagram.
LA shuts restaurants as virus surges, but Europe lockdowns to ease
A restaurant dining ban in Los Angeles was due to come into force on Nov. 25 as officials warned Americans to stay at home for the Thanksgiving holiday, while parts of Europe eyed looser lockdowns over the festive season.
WHO chief sees 'light at the end of long, dark tunnel'
With current vaccine developments, the light at the end of the COVID-19 tunnel is growing brighter, the World Health Organization (WHO) chief said on Nov. 23.
WHO Director-General Tedros Ghebreyesus gave an upbeat assessment on vaccine development after recent data showed that more COVID-19 cases had been reported in a recent 4 weeks than in first 6 months of the pandemic.
COVID-19 Vaccine: AstraZeneca and Oxford University Seek Approval after 'Effective' Trials
British drugs group AstraZeneca and the University of Oxford said on Monday they will seek regulatory approval for their coronavirus vaccine after "effective" trials, in the latest potential boost to curbing the global outbreak.
The partners announced that while the vaccine showed an average 70-percent effectiveness, the level jumped to 90 percent depending on dosage.
Μόσιαλος (ΘΕΜΑ 104,6): Στις αρχές της επόμενης χρονιάς θα έχουμε εμβόλιο
Εκτίμησε ότι πρώτα θα έρθει το εμβόλιο της Pfizer στην αγορά και αργότερα τα υπόλοιπα
AstraZeneca, Oxford say virus vaccine shows 70% efficacy
British drugs group AstraZeneca and the University of Oxford on Nov. 23 said their jointly-developed vaccine against COVID-19 has shown "an average efficacy of 70 percent" in trials.
Chinese virus vaccine on its way to Turkey, says health minister
A contract has been signed to buy a Chinese vaccine developed against COVID-19 and 10 million doses of the injection are already on their way to Turkey, Health Minister Fahrettin Koca has said.
Talks with Sinovac, the Chinese developer of the vaccine, and necessary legal procedures have been concluded, Koca told daily Hürriyet.